of aspirin appears to be an accepted approach.5-9 Restenosis after successful coronary angioplasty re-
Background. Intracoronary stents may be effective when used as "bail-out" devices for acute complications after percutaneous transluminal coronary angioplasty. Furthermore, preliminary reports have demonstrated some promising results with stents with regard to the reduction of restenosis. Several stent devices are available for preclinical and clinical evaluation. The use of these stainless-steel stents has been limited by poor visibility during fluoroscopy and thrombogenicity during the first days to weeks after implantation. We therefore investigated the immediate and short-term effects on arterial patency of a new, radiopaque, balloon-expandable coil stent in normal coronary arteries of pigs.
Methods and Results. In 10 animals, a stent was placed in two of the three epicardial coronary arteries. During the implantation procedure, the animals received heparin; after the procedure, no antithrombotic drugs were administered. After 1 week (five animals and 10 stents) or 4 weeks (five animals and 10 stents), repeat angiography was performed, followed by pressurefixation of the coronary arteries for light and electron microscopic examination. Angiographic analysis revealed that all stented coronary segments were patent and without signs of intraluminal defects. Scanning electron microscopy showed complete endothelial covering of all stents within 7 days. Light microscopy showed a reduced tunica media locally under the stent wires, which resulted from exerted pressure. The neointima on top of the stent wires measured 56 ,m (range, ,um) after 1 week and 139 ,um (range, 84-250 jum) after 4 weeks.
Conclusions. Results from this study show that this radiopaque endoprosthesis can be safely placed in normal coronary arteries of pigs. After 4 weeks, all stents were patent and there was no need for additional antithrombotic treatment, whereas neointimal proliferation was limited. (Circulation 1991;83:1788-1798) P ercutaneous transluminal coronary angioplasty can be used to treat patients with atherosclerotic coronary artery disease and has a high initial success rate. 12 However, in 2-5% of cases, acute or subacute occlusion at the angioplasty site occurs. [3] [4] Although the occluded artery can occasionally be successfully redilated, it is frequently necessary to proceed to emergency coronary bypass graft surgery.'3 The efficacy of pharmacological therapy on acute complications is still undetermined, although the administration mains, however, the second important factor that limits the efficacy of this procedure.'0.1" Pharmacological treatment to reduce the incidence of restenosis has so far been without effect,'2 although the addition of w-3 fatty acids to standard antithrombotic drugs has shown some promise.13 The implantation of vascular endoprostheses, attempted in the early days of angioplasty for the treatment of procedure-related complications,'4 may be useful in avoiding acute surgical intervention or preventing coronary restenosis.'5 Experimental and clinical experiences with these devices, however, indicate that their poor fluoroscopic visibility can make the implantation arduous. Furthermore, the thrombogenic nature of stainless-steel devices remains a concern, necessitating the administration of stringent anticoagulant therapy.6.17 We therefore studied the short-term angiographic patency of a new, radiopaque, tantalum stent after implantation in the coronary circulation in pigs. 
Methods

Balloon-Expandable Intracoronary Stent
The balloon-expandable stent used in the present study (Wiktor, Medtronic, Inc., Minneapolis, Minn.) is constructed of a single tantalum wire (0.127 mm diameter) formed into a sinusoidal wave and wrapped into a helical coil structure. This prosthesis is crimped onto the deflated polyethylene balloon of a standard angioplasty catheter ( Figure IA) . By inflating the balloon, the diameter of the stent increases without alteration of its length (Figure iB). The maximal diameter of the balloon after inflation determines the ultimate size of the prosthesis after implantation. One inflation at 8 atm is sufficient to open the stent and allows the safe withdrawal of the deflated balloon ( Figure 2 ). The diameters of the balloons of the mounted angioplasty catheters used in the present study were 3.0 and 3.5 mm, and the lengths of the prostheses ranged from 14 to 16 mm. For the balloon catheters used with stents of these sizes, the crimped stent profile is approximately 1.5 mm. An advantage of the delivery system used is that after stent expansion, the balloon will rewrap tightly without excessive winging, which will facilitate balloon removal from the deployed stent. The manufacturer has indicated that although this device may be deliverable with a variety of catheters, the device will be marketed as a ready-to-use complete delivery system to ensure the safe delivery of the stent by controlling the difficult crimping process during manufacture.
Animal Preparation
Experiments were performed in Yorkshire pigs (weight, 40- The investigations were performed according to the "Guide for the Care and Use of Laboratory Animals" (DHEW publication No. NIH-80-23, 1980), and the protocol was approved by the Committee on Experimental Animals of Erasmus University. After an overnight fast, the animals were sedated with 20 tggkg ketamine hydrochloride. After endotracheal intubation, the pigs were connected to a ventilator that administered a mixture of oxygen and nitrous oxide (1:2 vol/vol). Anesthesia was maintained with 1-4 vol% enflurane, and pancuronium bromide was used as a muscle relaxant. Antibiotic prophylaxis was administered by an intramuscular injection of 1,000 mg of a mixture of procaine penicillin G and benzathine penicillin G.
Under sterile conditions, an arteriotomy of the left carotid artery was performed, and a 9F introduction sheath was placed. Next, 5,000 IU heparin sodium was administered, and an 8F guiding catheter was advanced to the ascending aorta. After measurement of arterial blood pressure and heart rate and withdrawal of an arterial blood sample for the measurement of blood gases and acid-base balance (settings of the ventilator were corrected if necessary), left and right coronary angiography was performed using iopamidol (lopamiro 370, Dagra, Diemen, The Neth-erlands) as contrast agent. Eleven animals underwent the catheterization procedures. One animal was excluded from the study because angiography before stent implantation showed an occluded left coronary artery. At autopsy, air embolism of the coronary artery was demonstrated. Stent Implantation After angiography and with the diameter of the guiding catheter used as a reference, a segment with a diameter of 2.5 or 3.0 mm was selected in two of the three large coronary arteries (left anterior descending coronary artery, left circumflex coronary artery, and right coronary artery). No attempt was made to avoid side branches or angulated coronary segments. Then, a 3.0-mm (for 2.5-mm coronary segments) or 3.5-mm (for 3.0-mm coronary segments) balloon angioplasty catheter with a stent coil crimped on its deflated balloon was advanced over a 0.014-in. steerable guide wire to the site preselected for implantation. During all of our experiments, tracking and ease of placement in the coronary vasculature was good. After administration of an additional 2,500 IU heparin through the guiding catheter, the balloon was first inflated to a pressure of 8 atm for 30 seconds and then deflated, and negative pressure was maintained for 20 seconds. The angioplasty catheter was advanced slightly; if the marker in the middle of the balloon could be moved independent of the stent, the catheter was slowly withdrawn while leaving the stent in place. This implantation procedure was repeated in the second chosen coronary artery. (Implant sites are listed in Table 1 ). After repeat angiography of the stented coronary arteries, the guiding catheter and the introducer sheath were removed, the arteriotomy was repaired, and the skin was closed in two layers. The animals were allowed to recover from anesthesia; no postprocedure antithrombotic drugs were administered.
Follow-up Angiography
The catheterization procedure for follow-up angiography was identical to that described above. Coronary angiography was performed in the same projection as during implantation. Five animals (10 stents) were restudied after 1 week, whereas the other five animals (10 stents) were restudied after 4 weeks. Thereafter, the thorax was opened by a midsternal split, a lethal dose of sodium pentobarbital was injected intravenously, and immediate crossclamping of the ascending aorta was performed. After puncturing the aortic root above the coronary ostia, 500 ml of saline followed by 400 ml of buffered glutaraldehyde was infused under a pressure of 120 mm Hg. Then, the heart was excised, and the coronary arteries were dissected from the epicardial surface. The stented segments and adjacent unstented segments were placed in 4% formaldehyde and 1% glutaraldehyde in phosphate buffer (pH 7.3) for at least 48 hours in preparation for microscopy. Angiographic Analysis Coronary angiograms (preimplantation, immediately after implantation, and after 1 or 4 weeks) were analyzed using the quantitative coronary angiography analysis system (CAAS).18-20 Mean interpolated diameter at the site of stent placement was compared with the mean arterial diameter measured proximal and distal to the site of the stent.
Microscopic Examination
After fixation, the stent-containing arterial segments were divided lengthwise into two equal parts with a pair of fine scissors. The stent wires were removed from one half of each vessel. Both halves were washed in 0.1 M cacodylate buffer (pH 7.3), postfixed in 1% osmium tetroxide, and washed overnight in 0.1 M cacodylate buffer. The specimens were placed in 1% tannic acid for 60 minutes and 1% sodium sulfate for 10 minutes and again washed in 0.1 M cacodylate buffer. The vessel half containing the stent wires was dehydrated in graded ethanol series and critical point dried with liquid CO2. Thereafter, it was mounted on a specimen table and sputtercoated with gold before examination in a scanning microscope (ISI-DS-130, Akashi Beam Technology, Tokyo, Japan). The other half of each vessel was dehydrated in graded acetone and embedded in epon. After sectioning and staining, microscopy was performed with a light microscope (BH2, Olympus, Tokyo, Japan) and an electron microscope (EM400, Philips, Eindhoven, The Netherlands). For measurement of the thicknesses of the various layers of the arterial wall, at least two sections of each stented coronary segment were selected. The sections were cut 900 transverse (as determined by the diameter of the stent wire) and projected onto a video screen, and the outer contours, external and internal elastic lamina, and endothelial lining were traced using an integrated image analysis system (IBAS-2000, Kontron, Oberkochen, FRG). 21 The distance between the endothelial lining and the internal elastic lamina was taken as the thickness of the intima. 22 The media was defined as the layer between the internal and the external elastic lamina.
Statistical Analysis
All data are expressed as mean±SEM unless otherwise stated. The significance of the changes in the angiographic data was evaluated by Duncan's new multiple-range test once an analysis of variance revealed that the samples represented different populations (random block design). The histological measurements were analyzed by the two-sample Wilcoxon test. A probability of less than 0.05 was considered statistically significant.
Results
Systemic Hemodynamics and Blood Gases During Implantation and Follow-up Angiography
During implantation and follow-up angiography, heart rates (89+6 and 92±7 beats/min, respectively), systolic arterial blood pressures (120±+6 and 119±+6 mm Hg), and diastolic arterial blood pressures (82± 6 and 77±6 mm Hg) were comparable. The oxygenation of arterial blood and acid-base balance were also similar during stent placement and follow-up angiography and within the normal ranges (pH, 7.38±0.01; Po2, 144±9 mm Hg; PCO2, 43±1 mm Hg; base excess, 0.4+0.5 mmol/l).
Placement of Stent and Follow-up Angiography
A pilot study revealed that inflating the mounted balloon to as much as 6 atm was not sufficient to ensure the safe withdrawal of the balloon after deflation. Furthermore, withdrawal of the catheter after a deflation period of less than 10 seconds could also disengage the device. We were able to avoid these situations by using a single inflation of 30 seconds to 8 atm followed by at least 20 seconds of deflation before the catheter was withdrawn. Special care proved to be necessary when inserting the device through hemostasis valves, guiding catheters, or coronary segments too narrow for the catheter profile to avoid dislodging the stent from the loaded balloon. Therefore, the position of the stent mounted on the balloon was inspected after passing the hemostasis valve and before leaving the guiding catheter. In all 20 predetermined coronary segments (Table  1) , a stent could be placed. Quantitative analysis of the angiograms confirmed that we chose to use mounted angioplasty catheters with 3.0-mm balloons (supplier specified) for stent placement in 2.5+±0.1-mm artery diameters, that maximal inflated balloon diameters in these vessels were 3.0+0.1 mm (oversizing, 19±4%), and that the stented coronary segments after balloon deflation measured 2.6±0.1 mm (recoil, 9±+5%). For the supplier-specified, 3.5-mm balloon catheters, these values were preimplantation, 2.7±0.2 mm; during maximal inflation, 3 .2±0.1 mm (oversizing, 22±5%); and immediately after deflation, 2.9+0.1 mm (recoil, 9±4%). All animals survived the follow-up period. Repeat angiography revealed that all stented coronary arteries were patent after 1 and 4 weeks (Figure 3 ). Quantitative angiography showed that the mean diameters of the stented coronary segments after 1 and 4 weeks follow-up showed no statistically significant changes compared with the diameters immediately after placement (Figure 4 ). The diameter stenoses of the stent-containing coronary segments relative to the reference diameters proximal and distal to the stents measured 8±2% immediately after stent implantation, 15+4% at 1 week, and 17±4% at 4 weeks.
Light Microscopic Measurements
The stent wires were incorporated in the arterial wall as early as 1 week after implantation. Measurement of the several arterial layers showed that the neointima covering the wires had a median thickness of 56 ,um (range, ,um) after 1 week and increased to 139 gtm (range, 84-250 gum) after 4 weeks ( Figure 5 ). The neointima in the open or nonstrut areas of the stented segments had a median thickness of 25 ,um (range, 9-38 ,um ) after 1 week and increased to 48 ,gm (range, 6-120 jgm) after 4 weeks. The arterial media was considerably compressed under the stent wire. It was observed that in several vessels, the internal elastic lamina was disrupted at the wire site.
Light and Transmission Electron Microscopy
During the first week after stent implantation, neointimal hyperplasia was confined to the area in direct contact with the stent wires and consisted mainly of organized thrombi with a few layers of smooth muscle cells under the endothelial lining ( Figure 6A ). After 4 weeks, neointimal hyperplasia completely covered the stented coronary segments. A few foam cells and some erythrocytes were found in the neointima as a trace of the thrombotic event that took place at the time of implantation. The bulk of the neointima comprised smooth muscle cells with their typical organization, changing from a longitudinal to a circumferential orientation, beginning at the luminal side of the vessel ( Figure 6B) .
No inflammatory or foreign body reaction was observed at 1 or 4 weeks, based on the absence of giant cells or infiltrative changes in either layer of the vessel wall.
Scanning Electron Microscopy
Scanning electron microscopy showed that at 1 week after placement of the stents, all wires were completely covered with endothelium ( Figure 7A ). The coronary arteries, however, showed an undulated luminal surface. After 4 weeks, the stent wires were barely detectable under the neointimal surface ( Figure 7B ). Fine corrugation of this surface could be demonstrated, although adherent thrombi or platelet aggregates were not observed.
Discussion
Radiopacity
Vascular endoluminal prostheses (stents) are undergoing clinical evaluation for their usefulness as scaffolding devices for acute occlusion after coronary angioplasty. 15, 16, 23, 24 The efficacy of these devices has also been studied in the prevention and treatment of restenosis in aortocoronary bypass grafts and the native coronary circulation.'1525-28Although the longterm effect of stents used for these indications is still not determined, immediate angiographic results are excellent, and there is improvement during the first 24 hours.29 However, the poor visibility of thin-wired, stainless-steel devices during fluoroscopy is a disadvantage during implantation. Both the inability to place stainless-steel, balloon-expandable stents at preselected arterial sites and systemic embolization have been reported experimentally and clinically.30-32 Furthermore, uncertainty about the precise placement of nonradiopaque stents will complicate the determination of immediate efficacy and late restenosis in the coronary segments in which the stent purportedly was placed. The stent used in the present study has the distinct advantage of being clearly visible under fluoroscopy (Figure 3 ), thus facilitating its safe placement.33 With this device, there can be no discussion about which coronary segment is covered by it and which is not. Quantitative angiographic assessment is simplified, but not all problems have been solved; preliminary (unpublished) data from our laboratory show that videoden- STENT, coronary segment immediately after stent placement (n =20); 1 WEEK, measurements offive animals (nine stents) 1 week after stent placement; 4 WEEKS, measurements offive animals (10 stents) 4 weeks after stent placement. *p<0.05 versus balloon. sitometric assessment will be influenced by the presence of any type of stent. Thrombogenicity Another major problem with stainless-steel stents is that they require elaborate anticoagulation therapy after implantation because of their thrombogenicity, which will increase the risk of complications associated with a hemorrhagic diathesis. In the present study, all stented coronary arterial segments were angiographically patent after 1 and 4 weeks without any signs of intraluminal defects, with antithrombotic drugs not administered during follow-up. Although we cannot exclude that intercurrent thrombi or plate- let aggregates were formed during the first few days after implantation, stent occlusion did not occur; after 1 week, scanning microscopy showed a clean endothelial surface covering the stents. If thrombotic material of considerable size had embolized before that time, deaths would have occurred because the risk of lethal arrhythmias after coronary occlusion is very high in this species. That all animals survived may serve as circumstantial evidence against the occurrence of embolization of thrombus material. Thrombotic events associated with the stent have been reported experimentally in as many as 40% of study groups using other stents but can be reduced by choosing appropriate antithrombotic regimens. 30, 3134, 35 The nonthrombogenic feature of this stent is not determined, but several factors may be involved. First, the metal itself (tantalum) may be a major determinant. The wire surface of any stent may undergo oxidation after implantation, and the resultant oxide, in this case, tantalum oxide, is not only very stable (implying fewer changes in surface charge) but also corrosion resistant. 36 Second, there is a large area of open space (91.6% and 92.3% for 3.0-and 3.5-mm expanded diameters, respectively) between the wires, resulting in less metal per surface area. Third, the entire stent surface is smooth. Finally, there is early endothelial covering (after 1 week, the Wiktor stents were completely covered by an endothelium-covered neointima).
Neointimal Hyperplasia
At 1 week after implantation, the luminal surface of the artery showed an undulated appearance. This may cause local turbulence in blood flow and fluctuations in wall shear stress, which may be factors determining endothelial cell turnover and intimal hyperplasia. [37] [38] [39] [40] We could demonstrate that the thickness of the neointimal layer had considerably increased between 1 and 4 weeks after implantation. After 4 weeks, the luminal surfaces of the stented coronary segments were smooth. Future studies are necessary to determine whether the increase in intimal thickness levels off after 4 weeks. However, the median thickness of the neointima in the present study was not different from that reported for other types of stents.30,3141 Schwartz et a142 emphasized that rupture of the internal elastic membrane after stenting may form a trigger for accelerated neointimal hyperplasia, but we observed considerable damage to this elastic lamina in several cases without significant restenosis (e.g., see Figure 6B ). Other factors, such as considerable oversizing of the prosthesis with resultant damage to the arterial media, are probably involved.
Elastic Recoil
A potential beneficial effect of self-expanding stents is the prevention of elastic recoil after coronary angioplasty. 29 The balloon-expandable Wiktor stent lacks this effect, perhaps because of its passive radial force and relatively large area of open space. Quantitative angiographic assessment showed a recoil of 9% immediately after placement of the stent (Figure 4 ). Data Under a layer of neointimal hyperplasia, the stent wire coil (arrows) is hardly visible. An embedded stent wire partly overhangs a side branch (S). W cut face of vessel wall. from other balloon-expandable stents are not available or inconclusive. In vitro studies using another type of balloon-expandable tantalum stent also point toward considerable recoil.43 However, which feature (metal or design) determines the elastic properties of a stent remains unknown.
Conclusion
Interpretation of the data obtained in the present study must be made with consideration that it involves the evaluation of a new device in normal coronary arteries of experimental animals. However, comparison of the results of the present study with data obtained for other stent devices in healthy experimental animals indicates that the Wiktor stent is less thrombogenic.3031t35 Whether this will also be true in atherosclerotic coronary arteries in swine, in which at least one of the other stent devices showed a low complication rate,44 remains to be demonstrated. Also, the clear visibility of the Wiktor stent under fluoroscopy is a distinct advantage.
